Abbott Laboratories ABT
News
Innovating for a Healthier, Sustainable Future
Abbott Teams Up With the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health
Abbott Declares 402nd Consecutive Quarterly Dividend
Biowearables 101: Health Tech That Goes Deeper
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients
Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vitally Important
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
It’s Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team
Abbott Laboratories on Pace for Largest Percent Decrease Since October 2023 — Data Talk
Abbott Labs' first-quarter results top estimates amid strong medical-device sales
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
Abbott Gets FDA Approval for TriClip Heart Valve Repair System
Abbott Laboratories Cartridge Gets FDA Clearance to be Used with Whole Blood
Here's what families need to know after a landmark $60 million verdict in baby-formula suit
Enfamil maker vows to fight $60 million baby-formula verdict as stock slides
Abbott Laboratories On Track for Largest Percent Decrease Since October 2023 — Data Talk
Abbott Laboratories says FDA independent panel votes to approve heart device